These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Mannucci PM; Ruggeri ZM; Pareti FI; Capitanio A Lancet; 1977 Apr; 1(8017):869-72. PubMed ID: 67283 [TBL] [Abstract][Full Text] [Related]
8. [The position of a vasopressin derivative ("DDAVP") in the treatment of haemophilia A (author's transl)]. Blättler W; Jacky E; Müller M; Graf M; Meili E Ther Umsch; 1979 Apr; 36(4):330-3. PubMed ID: 377557 [No Abstract] [Full Text] [Related]
9. [DDAVP and its effect on factor VIII activity (author's transl)]. Sikorová J; Vorlová Z Cas Lek Cesk; 1981 May; 120(18):553-6. PubMed ID: 6794913 [No Abstract] [Full Text] [Related]
10. DDAVP and cryoprecipitate in mild haemophilia. Boulton FE; Smith A Lancet; 1979 Sep; 2(8141):535. PubMed ID: 90263 [No Abstract] [Full Text] [Related]
11. Desmopressin therapy in patients with acquired factor VIII inhibitors. Naorose-Abidi SM; Bond LR; Chitolie A; Bevan DH Lancet; 1988 Feb; 1(8581):366. PubMed ID: 2893182 [No Abstract] [Full Text] [Related]
12. 1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor. Muhm M; Grois N; Kier P; Stümpflen A; Kyrle P; Pabinger I; Bettelheim P; Hinterberger W; Lechner K Haemostasis; 1990; 20(1):15-20. PubMed ID: 2108912 [TBL] [Abstract][Full Text] [Related]
13. Effect of stanozolol on factors VIII and IX and serum aminotransferases in haemophilia. Greer IA; Greaves M; Madhok R; McLoughlin K; Porter N; Lowe GD; Preston FE; Forbes CD Thromb Haemost; 1985 Jun; 53(3):386-9. PubMed ID: 3931287 [TBL] [Abstract][Full Text] [Related]
14. [Extractions in hemophilic patients. Control of hemostasis with DDAVP]. Pignanelli M; Rota L; Pignanelli C Dent Cadmos; 1988 Oct; 56(15):80-6, 89. PubMed ID: 2978643 [No Abstract] [Full Text] [Related]
15. DDAVP in haemophilia and von Willebrand's disease. Lancet; 1983 Oct; 2(8353):774-5. PubMed ID: 6137606 [No Abstract] [Full Text] [Related]
16. Intranasal DDAVP: biological and clinical evaluation in mild factor VIII deficiency. Chistolini A; Dragoni F; Ferrari A; La Verde G; Arcieri R; Ege Mohamud A; Mazzucconi MG Haemostasis; 1991; 21(5):273-7. PubMed ID: 1806455 [TBL] [Abstract][Full Text] [Related]
17. [DDAVP: alternative to replacement treatment in mild haemophilia A and von Willebrand-Jürgens syndrome (author's transl)]. Theiss W; Sauer E Dtsch Med Wochenschr; 1977 Dec; 102(48):1769-72. PubMed ID: 303563 [TBL] [Abstract][Full Text] [Related]
18. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease]. Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405 [TBL] [Abstract][Full Text] [Related]
19. A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired hemophilia A with high-titer inhibitor. Gandini G; Franchini M; Manzato F; Lippi G; Aprili G Haematologica; 1999 Nov; 84(11):1054. PubMed ID: 10553173 [No Abstract] [Full Text] [Related]
20. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease]. Fukui H; Takase T Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720 [No Abstract] [Full Text] [Related] [Next] [New Search]